Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of 10 mg rivaroxaban tablets vs originator in healthy Thai volunteers under fasting
TCTR20221017002Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rivaroxaban (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on TCTR20221017002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221017002.